- Filed
- May 11, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · May 13, 2026 | 162.09M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 162.09M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 162.09M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 161.81M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 161.81M sh |
| Capex | Q3 2026 · Mar 31, 2026 | $230.48K |
| Capex | Q3 2026 · Mar 31, 2025 | $39.61K |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | $64.93K |
| Operating Cash Flow restated | Q3 2026 · Mar 31, 2025 | −$437.75K |
| Long Term Debt | Q3 2026 · Mar 31, 2026 | $2.23M |
| Short Term Debt | Q3 2026 · Mar 31, 2026 | $135.41K |
| Short Term Debt | Q3 2026 · Jun 30, 2025 | $293.76K |
| Cash And Equivalents | Q3 2026 · Mar 31, 2026 | $78.83K |
| Cash And Equivalents | Q3 2026 · Jun 30, 2025 | $25.27K |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | −$2.87M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | −$2.87M |
| Stockholders Equity | Q3 2026 · Sep 30, 2025 | −$2.58M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | −$2.39M |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | −$1.71M |
| Stockholders Equity | Q3 2026 · Dec 31, 2024 | −$1.22M |
| Stockholders Equity | Q3 2026 · Sep 30, 2024 | −$863.58K |
| Stockholders Equity | Q3 2026 · Jun 30, 2024 | −$560.14K |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $4.91M |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $4.72M |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $7.82M |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $6.83M |
| Current Assets | Q3 2026 · Mar 31, 2026 | $721.62K |
| Current Assets | Q3 2026 · Jun 30, 2025 | $279.62K |
| Total Assets | Q3 2026 · Mar 31, 2026 | $4.95M |
| Total Assets | Q3 2026 · Jun 30, 2025 | $4.43M |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | $0.00 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $0.00 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $0.00 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | $0.00 |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $201.01K |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $439.82K |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $70.27K |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $244.28K |
| Net Income | Q3 2026 · Mar 31, 2026 | −$306.01K |
| Net Income | Q3 2026 · Mar 31, 2026 | −$718.96K |
| Net Income | Q3 2026 · Dec 31, 2025 | −$226.7K |
| Net Income | Q3 2026 · Sep 30, 2025 | −$186.25K |
| Net Income | Q3 2026 · Mar 31, 2025 | −$485.08K |
| Net Income | Q3 2026 · Mar 31, 2025 | −$1.18M |
| Net Income | Q3 2026 · Dec 31, 2024 | −$358.64K |
| Net Income | Q3 2026 · Sep 30, 2024 | −$333.33K |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$279.94K |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$643.12K |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$455.23K |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$1.09M |
| Gross Profit | Q3 2026 · Mar 31, 2026 | −$78.94K |
| Gross Profit | Q3 2026 · Mar 31, 2026 | −$203.3K |
| Gross Profit | Q3 2026 · Mar 31, 2025 | −$384.96K |
| Gross Profit | Q3 2026 · Mar 31, 2025 | −$846.51K |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $413.7K |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $1.26M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2025 | $582.9K |
| Cost Of Revenue | Q3 2026 · Mar 31, 2025 | $1.62M |
| Revenue | Q3 2026 · Mar 31, 2026 | $334.77K |
| Revenue | Q3 2026 · Mar 31, 2026 | $1.06M |
| Revenue | Q3 2026 · Mar 31, 2025 | $197.94K |
| Revenue | Q3 2026 · Mar 31, 2025 | $771.45K |